Acer Biosciences Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Investors
  • 4

Acer Biosciences General Information

Description

Provider of preclinical research capabilities designed to support drug discovery and development. The company offers in vivo efficacy studies, bioanalytical testing, pharmacokinetics assessments, and disease model expertise, enabling pharmaceutical and biotechnology companies to evaluate therapeutic candidates and improve research outcomes.

Contact Information

Website
www.acerbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 300, Jingyuan Road, Shuangliu District
  • Chengdu Tianfu International Bio-city
  • Chengdu, Sichuan 610000
  • China
+86 028
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • Number 300, Jingyuan Road, Shuangliu District
  • Chengdu Tianfu International Bio-city
  • Chengdu, Sichuan 610000
  • China
+86 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acer Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A1) 23-Jun-2026 Completed Generating Revenue
3. Secondary Transaction - Private 26-Sep-2023 Completed Generating Revenue
2. Later Stage VC 21-Aug-2023 Completed Generating Revenue
1. Later Stage VC 07-Nov-2022 Completed Generating Revenue
To view Acer Biosciences’s complete valuation and funding history, request access »

Acer Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
CapitalEdge Investment Management Hedge Fund Minority
Y.R.Delta Fund Growth/Expansion Minority
Shanghai Wenzhou Capital Growth/Expansion Minority
Chengdu Bio-Town Investment Government Minority
To view Acer Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial

Acer Biosciences FAQs

  • When was Acer Biosciences founded?

    Acer Biosciences was founded in 2016.

  • Where is Acer Biosciences headquartered?

    Acer Biosciences is headquartered in Chengdu, China.

  • What industry is Acer Biosciences in?

    Acer Biosciences’s primary industry is Drug Discovery.

  • Is Acer Biosciences a private or public company?

    Acer Biosciences is a Private company.

  • What is Acer Biosciences’s current revenue?

    The current revenue for Acer Biosciences is .

  • Who are Acer Biosciences’s investors?

    CapitalEdge Investment Management, Y.R.Delta Fund, Shanghai Wenzhou Capital, and Chengdu Bio-Town Investment have invested in Acer Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process